staurosporine aglycone has been researched along with Leukemia, Myeloid in 1 studies
staurosporine aglycone: metabolite from culture broth of Nocardiopsis sp.; a neurotrophin antag; inhibits BDNF TrkB receptor
Leukemia, Myeloid: Form of leukemia characterized by an uncontrolled proliferation of the myeloid lineage and their precursors (MYELOID PROGENITOR CELLS) in the bone marrow and other sites.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kinoshita, K | 1 |
| Hidaka, H | 1 |
| Ohkuma, S | 1 |
1 other study available for staurosporine aglycone and Leukemia, Myeloid
| Article | Year |
|---|---|
Induction of phagocytic activity of M1 cells by an inhibitor of vacuolar H+-ATPase, bafilomycin A1.
Topics: Animals; Anti-Bacterial Agents; Carbazoles; Cinnamates; Ethers, Cyclic; Growth Inhibitors; Indole Al | 1994 |